Single‐Cell and Multiomics Characterization of p21 in Cancer Progression and Therapeutic Sensitivity
Abstract Introduction: CDKN1A (encoding p21) is a canonical regulator of cell cycle arrest and genomic stability. However, its functional spectrum…
Abstract Introduction: CDKN1A (encoding p21) is a canonical regulator of cell cycle arrest and genomic stability. However, its functional spectrum…
Abstract Thyroid cancer exhibits pronounced cellular heterogeneity, yet the mechanisms underlying epithelial–mesenchymal transition (EMT) and tumor microenvironment (TME) remodeling remain…
Abstract Background: As the most lethal neuroendocrine tumor, small cell lung cancer (SCLC) can drive its progression by hijacking neuronal…
Abstract Hepatocellular carcinoma (HCC) remains a therapeutic challenge due to tumor microenvironment heterogeneity and metabolic reprogramming. Short-chain dehydrogenase/reductase 3, DHRS3,…
Abstract Background: Colon cancer remains one of the leading causes of cancer-related deaths worldwide and is associated with high rates…
Abstract Background: CYP19A1, which encodes the enzyme aromatase necessary for estrogen production, is known to be involved in hormone-sensitive cancers,…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s12672-026-04992-4. Article type: Research Article Keywords: BANF1, Lung adenocarcinoma,…
Abstract Glioblastoma (GBM) remains one of the most lethal brain tumors, with current therapies offering limited benefits and high relapse…
Abstract This review delves into the characteristics of lipid metabolism reprogramming in cancer cells and immune cells within the tumor…
Abstract Numerous studies in various cancer models have demonstrated that ingredients of cannabis can influence tumor growth through the endocannabinoid…